A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

S M Srinivasula1, R Hegde, A Saleh

  • 1Center for Apoptosis Research and the Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Nature
|March 10, 2001
PubMed

Insights

X-linked inhibitor-of-apoptosis protein (XIAP) binds caspase-9, inhibiting apoptosis. Smac protein binding to XIAP disrupts this interaction, promoting apoptosis by releasing caspase-9 activity. This reveals a key regulatory mechanism in programmed cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • X-linked inhibitor-of-apoptosis protein (XIAP) is a key regulator of apoptosis, inhibiting caspase activity.
  • Smac (DIABLO) antagonizes XIAP, promoting apoptosis by relieving caspase inhibition.

Purpose of the Study:

  • To elucidate the molecular mechanism by which XIAP interacts with and inhibits caspase-9.
  • To investigate how Smac binding to XIAP affects caspase-9 activity and apoptosis.

Main Methods:

  • Site-directed mutagenesis to abrogate procaspase-9 processing at Asp315.
  • Deletion mutagenesis of the caspase-9 linker peptide.
  • Analysis of XIAP-caspase-9 complex formation and inhibition assays.

Main Results:

  • XIAP binds to the processed amino terminus of the caspase-9 linker peptide within the active caspase-9-Apaf-1 complex.
  • Mutations preventing linker processing or deletion of the linker abrogated XIAP binding and inhibition.
  • Cascase-9 linker peptide and Smac binding to XIAP's BIR3 domain are mutually exclusive, with Smac disrupting the XIAP-linker interaction.

Conclusions:

  • XIAP inhibits caspase-9 activity through direct binding to its processed linker peptide.
  • Smac potentiates caspase-9 activity and apoptosis by competitively displacing the caspase-9 linker from XIAP's BIR3 domain.
  • This identifies a conserved mechanism involving opposing peptide interactions with XIAP that regulate apoptosis.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...